Elevated serum HER-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer

Allan Lipton, S. M. Ali, K. Leitzel, Laurence Demers, Vernon Chinchilli, L. Engle, Harold Harvey, C. Brady, C. M. Nalin, M. Dugan, W. Carney, J. Allard

Research output: Contribution to journalArticlepeer-review

233 Scopus citations

Fingerprint

Dive into the research topics of 'Elevated serum HER-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences